NHN Investment
About NHN Investment
NHN Investment is a South Korean venture capital firm specializing in early to growth-stage investments across various sectors, including technology and healthcare. The firm focuses on companies in data analytics, e-commerce, and artificial intelligence, aiming to support innovative ideas with significant impact potential. With a strategic approach that emphasizes a data-driven methodology, NHN Investment has led over 30 deals, showcasing a strong track record in early to growth-stage investments. The firm's portfolio includes notable companies such as Syte.ai, ImmunoMet Therapeutics, and tru.ID. NHN Investment's investment philosophy centers on partnering with startups that demonstrate the potential for substantial growth and market influence, providing not only capital but also technological guidance to foster their development into successful ventures.
Investment Mandate
Investment Stages7
Asset Classes1
Geographical Focus
African markets1
EgyptOther stated markets4
Requirements
Innovative technology solutions, Scalable business models, Strong management teams, Potential for significant market impact
Stated Portfolio11
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error